PATENT CLAIM ANALYSIS

Application Number: 16298460
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["540", "586000"]

Abstract:
There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (I)).

Claim (Index 8):
The process of  claim 7  wherein the C 1-6 alkyl group is ethyl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.35294
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15902077', '15642637', '16033464', '15305003', '15516809']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7190508961670246
- 35 USC 102 Novelty (BERT): 0.5147771174809269
- Combined Prediction Score: 0.6986235182984148
- Mean Citation Score: 280.18966
- Max Citation Score: 288.6595
- Similarity Product: 213.2343992667198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test